Free tool
FAERS Monitor: Xanax
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018276 or its brand name (Xanax, Alprazolam). Reports on generic versions are filed under their own applications.
Reports
206,207
Serious
145,716
71% of reports
Hospitalization
66,078
Death reported
33,581
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective13,712
- nausea13,127
- fatigue12,245
- drug abuse11,216
- anxiety10,362
- headache10,157
- pain10,015
- toxicity to various agents9,150
- diarrhoea9,063
- dyspnoea8,506
- dizziness8,059
- completed suicide7,664
- off label use7,368
- vomiting7,323
- depression7,321
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3,033 |
| 2005 | 3,587 |
| 2006 | 3,453 |
| 2007 | 3,248 |
| 2008 | 4,038 |
| 2009 | 4,902 |
| 2010 | 7,773 |
| 2011 | 7,857 |
| 2012 | 9,738 |
| 2013 | 9,564 |
| 2014 | 10,329 |
| 2015 | 14,025 |
| 2016 | 14,471 |
| 2017 | 13,446 |
| 2018 | 14,823 |
| 2019 | 15,422 |
| 2020 | 14,572 |
| 2021 | 10,483 |
| 2022 | 9,637 |
| 2023 | 8,833 |
| 2024 | 8,524 |
| 2025 | 8,392 |
| 2026 | 6,050 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,847,952 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug abuseSignal | 11,216 | 15.7 | 15.4 | 134,359 |
| completed suicideSignal | 7,664 | 10.2 | 10.0 | 58,173 |
| toxicity to various agentsSignal | 9,150 | 5.8 | 5.7 | 34,601 |
| anxietySignal | 10,362 | 3.8 | 3.7 | 21,033 |
| depressionSignal | 7,321 | 3.4 | 3.3 | 11,856 |
| nausea | 13,127 | 1.7 | 1.7 | 3,896 |
| pain | 10,015 | 1.7 | 1.6 | 2,753 |
| headache | 10,157 | 1.7 | 1.6 | 2,723 |
| dizziness | 8,059 | 1.7 | 1.6 | 2,124 |
| fatigue | 12,245 | 1.6 | 1.6 | 2,922 |
| vomiting | 7,323 | 1.6 | 1.6 | 1,649 |
| dyspnoea | 8,506 | 1.5 | 1.5 | 1,633 |
| diarrhoea | 9,063 | 1.4 | 1.4 | 1,231 |
| drug ineffective | 13,712 | 1.1 | 1.0 | 52 |
| off label use | 7,368 | 0.9 | 0.8 | 182 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.